Measurement of plasma glucagon in humans: A shift in the performance of a current commercially available radioimmunoassay kit

doi:10.1111/dom.14673

. 2022 Jun;24(6):1182-1184.

doi: 10.1111/dom.14673. Epub 2022 Mar 8.

Measurement of plasma glucagon in humans: A shift in the performance of a current commercially available radioimmunoassay kit

Tongzhi Wu^{1

2}, Christopher K Rayner^{1

3}, Karen L Jones^{1

2}, Michael Horowitz^{1

2}, Christine Feinle-Bisset¹, Scott D Standfield¹, Cong Xie^{1

2}, Carolyn F Deacon⁴, Jens J Holst⁴, Nicolai J Wewer Albrechtsen^{4

5

6}

Affiliations

¹ Adelaide Medical School and Centre of Research Excellence (CRE) in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide, South Australia, Australia.
² Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
³ Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
⁴ Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
⁵ Novo Nordisk Foundation Centre for Protein Research, University of Copenhagen, Copenhagen, Denmark.
⁶ Department of Clinical Biochemistry, Diagnostic Center, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.

PMID: 35188324
DOI: 10.1111/dom.14673

Measurement of plasma glucagon in humans: A shift in the performance of a current commercially available radioimmunoassay kit

Tongzhi Wu et al. Diabetes Obes Metab. 2022 Jun.

. 2022 Jun;24(6):1182-1184.

doi: 10.1111/dom.14673. Epub 2022 Mar 8.

Authors

Affiliations

¹ Adelaide Medical School and Centre of Research Excellence (CRE) in Translating Nutritional Science to Good Health, The University of Adelaide, Adelaide, South Australia, Australia.
² Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
³ Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
⁴ Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
⁵ Novo Nordisk Foundation Centre for Protein Research, University of Copenhagen, Copenhagen, Denmark.
⁶ Department of Clinical Biochemistry, Diagnostic Center, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.

PMID: 35188324
DOI: 10.1111/dom.14673

No abstract available

PubMed Disclaimer

Cited by

Postprandial Dynamics of Proglucagon Cleavage Products and Their Relation to Metabolic Health.
Wagner R, Eckstein SS, Fritsche L, Prystupa K, Hörber S, Häring HU, Birkenfeld AL, Peter A, Fritsche A, Heni M. Wagner R, et al. Front Endocrinol (Lausanne). 2022 Jun 29;13:892677. doi: 10.3389/fendo.2022.892677. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35872982 Free PMC article. Clinical Trial.
The relationship between insulin and glucagon concentrations in non-diabetic humans.
Laurenti MC, Arora P, Dalla Man C, Andrews JC, Rizza RA, Matveyenko A, Bailey KR, Cobelli C, Vella A. Laurenti MC, et al. Physiol Rep. 2022 Jul;10(13):e15380. doi: 10.14814/phy2.15380. Physiol Rep. 2022. PMID: 35822422 Free PMC article.

References

REFERENCES

1. Lund A, Bagger JI, Wewer Albrechtsen NJ, et al. Evidence of extrapancreatic glucagon secretion in man. Diabetes. 2016;65(3):585-597.
1. Wu T, Rayner CK, Marathe CS, Jones KL, Horowitz M. Glucagon receptor signalling - backwards and forwards. Expert Opin Investig Drugs. 2018;27(2):135-138.
1. Xie C, Wang X, Jones KL, et al. Role of endogenous glucagon-like peptide-1 enhanced by vildagliptin in the glycaemic and energy expenditure responses to intraduodenal fat infusion in type 2 diabetes. Diabetes Obes Metab. 2020;22(3):383-392.
1. Borg MJ, Bound M, Grivell J, et al. Comparative effects of proximal and distal small intestinal administration of metformin on plasma glucose and glucagon-like peptide-1, and gastric emptying after oral glucose, in type 2 diabetes. Diabetes Obes Metab. 2019;21(3):640-647.
1. Jones KL, Rigda RS, Buttfield MDM, et al. Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycaemia in healthy people and people with type 2 diabetes. Diabetes Obes Metab. 2019;21(5):1158-1167.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley

[1] Lund A, Bagger JI, Wewer Albrechtsen NJ, et al. Evidence of extrapancreatic glucagon secretion in man. Diabetes. 2016;65(3):585-597.

[2] Lund A, Bagger JI, Wewer Albrechtsen NJ, et al. Evidence of extrapancreatic glucagon secretion in man. Diabetes. 2016;65(3):585-597.

[3] Wu T, Rayner CK, Marathe CS, Jones KL, Horowitz M. Glucagon receptor signalling - backwards and forwards. Expert Opin Investig Drugs. 2018;27(2):135-138.

[4] Wu T, Rayner CK, Marathe CS, Jones KL, Horowitz M. Glucagon receptor signalling - backwards and forwards. Expert Opin Investig Drugs. 2018;27(2):135-138.

[5] Xie C, Wang X, Jones KL, et al. Role of endogenous glucagon-like peptide-1 enhanced by vildagliptin in the glycaemic and energy expenditure responses to intraduodenal fat infusion in type 2 diabetes. Diabetes Obes Metab. 2020;22(3):383-392.

[6] Xie C, Wang X, Jones KL, et al. Role of endogenous glucagon-like peptide-1 enhanced by vildagliptin in the glycaemic and energy expenditure responses to intraduodenal fat infusion in type 2 diabetes. Diabetes Obes Metab. 2020;22(3):383-392.

[7] Borg MJ, Bound M, Grivell J, et al. Comparative effects of proximal and distal small intestinal administration of metformin on plasma glucose and glucagon-like peptide-1, and gastric emptying after oral glucose, in type 2 diabetes. Diabetes Obes Metab. 2019;21(3):640-647.

[8] Borg MJ, Bound M, Grivell J, et al. Comparative effects of proximal and distal small intestinal administration of metformin on plasma glucose and glucagon-like peptide-1, and gastric emptying after oral glucose, in type 2 diabetes. Diabetes Obes Metab. 2019;21(3):640-647.

[9] Jones KL, Rigda RS, Buttfield MDM, et al. Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycaemia in healthy people and people with type 2 diabetes. Diabetes Obes Metab. 2019;21(5):1158-1167.

[10] Jones KL, Rigda RS, Buttfield MDM, et al. Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycaemia in healthy people and people with type 2 diabetes. Diabetes Obes Metab. 2019;21(5):1158-1167.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Measurement of plasma glucagon in humans: A shift in the performance of a current commercially available radioimmunoassay kit

Affiliations

Measurement of plasma glucagon in humans: A shift in the performance of a current commercially available radioimmunoassay kit

Authors

Affiliations

Similar articles

Cited by

References

REFERENCES

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Similar articles

Cited by

References

REFERENCES

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources